Read the Summary of Proceedings from the second Biomarkers Consortium Meeting, held on February 3, 2016, in Atlanta, Georgia.
A Call-to-Action to Accelerate Development and Adoption of Biomarkers
The Need As many as one in twelve pregnancies is affected by hypertension in its most dangerous form – preeclampsia. In some regions of the country 15-20% of pregnancies are affected. The curre...
Order our Ask About Aspirin Rack Card. Aspirin can prevent the formation of blood clots. This can make aspirin useful in treating or preventing some conditions like heart attacks and stroke...
Heart disease is the leading cause of death for women and appears to be increasing in women aged 35 to 54 years. Women who have had preeclampsia have three to four times the risk of high...
September 25, 2020 – Melbourne, FL –– The Preeclampsia Foundation is urgently calling for the development of biomarker tests for simple, rapid, and accurate diagnosis and prediction...
May 19, 2020 - Melbourne, FL - The Preeclampsia Foundation is responding to the needs of pregnant and postpartum women, during COVID-19, with the introduction of The Cuff Kit™. With w...
Foundation joins Brigham and Women’s investigators on important research study Preeclampsia puts women at increased risk for heart disease as well as stroke and high blood pressure later in lif...
Melbourne, Florida – December 12, 2018 – The Preeclampsia Foundation is pleased to announce MoMMA’s Voices, a national coalition of patient organizations and individuals with lived e...
This is a great day for preeclampsia and the beginning of the end of needless deaths. Late last night, President Trump signed into law the Preventing Maternal Deaths Act. We are very proud and incredi...